{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T19:56:53Z","timestamp":1769543813807,"version":"3.49.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>\n                    Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease characterized by uncontrolled complement activation and is associated with various genetic factors, including multiple variants at the gene locus encoding the complement component 3 (C3). However, only a few functional amino acid substitutions have been identified in C3. We report a pediatric case of aHUS presenting with refractory hypertension and massive gastrointestinal bleeding. Comprehensive histopathological, immunohistochemical, genetic, and molecular structural analyses were performed. Biopsy specimens were stained for renin and the membrane-attack complex of the complement system (C5b-9). Plasma levels of the Ba fragment of complement factor B were measured to evaluate the alternative pathway activation. Genomic DNA was obtained with consent and analyzed by targeted next-generation sequencing using a custom gene panel, followed by Sanger sequencing for variant confirmation. The possible effects of the identified amino acid substitution on the molecular structure of C3 were analyzed using computer-aided simulation with MODELLER and DoGSiteScorer. As a result, the juxtaglomerular apparatus was hyperplastic and intensely stained for renin. Endothelial cells of renal and intestinal blood vessels were positive for C5b-9. The plasma Ba level was elevated compared to the control level. The ileal and colonic mucosae were denuded and highly edematous, with epithelial cells undergoing regenerative and metaplastic changes in the active phase. Mucosal blood vessels contained intraluminal red cell fragments and neutrophils attached to swollen endothelial cells. However, the colonic mucosa showed near-normal histology after disease convalescence. Genetic analyses identified a single nucleotide C3 variant NM_000064.4(C3):c.4811T&amp;gt;C (p.Met1604Thr), resulting in an M\n                    <jats:sub>1604<\/jats:sub>\n                    T substitution in the functional C345C domain. Molecular structural analyses indicated that this amino acid substitution can cause the formation of a large cavity within the hydrophobic core of the C-terminal domain, possibly destabilizing the spherical structure of C3. Our study highlights that the M\n                    <jats:sub>1604<\/jats:sub>\n                    T substitution in the C3 C345C domain may drive the observed excessive complement activation, C5b-9 deposition on endothelial cells, and severe circulatory disturbances in the intestinal mucosa.\n                  <\/jats:p>","DOI":"10.3389\/fped.2025.1710286","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:41Z","timestamp":1769495981000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["C3 molecular structural and histopathological analyses in a pediatric case of atypical hemolytic uremic syndrome with life-threatening gastrointestinal bleeding\u2014a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Takuji","family":"Enya","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]},{"name":"Department of Immunology, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakina","family":"Kuge","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kondou","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Nara Hospital","place":["Nara, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Joh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Jikei University Hospital","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"China","family":"Nagano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine","place":["Kobe, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandai","family":"Nozu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine","place":["Kobe, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo","place":["Tokyo, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Hakata","sequence":"additional","affiliation":[{"name":"Department of Immunology, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kindai University Faculty of Medicine","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Miyazawa","sequence":"additional","affiliation":[{"name":"Department of Immunology, Kindai University Faculty of Medicine","place":["Osaka, Japan"]},{"name":"Kindai University","place":["Osaka, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3580","DOI":"10.3390\/cells10123580","article-title":"Pediatric atypical hemolytic uremic syndrome advances","volume":"10","author":"Raina","year":"2021","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1182\/asheducation-2016.1.217","article-title":"Atypical hemolytic uremic syndrome","volume":"2016","author":"Afshar-Kharghan","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2147\/JMDH.S245620","article-title":"Atypical hemolytic-uremic syndrome: genetic basis, clinical manifestations, and a multidisciplinary approach to management","volume":"16","author":"Yerigeri","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atipical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/S0021-9258(19)75665-8","article-title":"Alternative complement pathway activation fragment Ba binds to C3b. Evidence that formation of the factor B-C3b complex involves two discrete points of contact","volume":"262","author":"Pryzdial","year":"1987","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00467-018-3933-3","article-title":"Extra-renal manifestations of atypical hemolytic uremic syndrome in children","volume":"33","author":"Fidan","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","article-title":"An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome","volume":"29","author":"Johnson","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5414\/CNCS109511","article-title":"Comorbidity of inflammatory bowel disease with atypical hemolytic uremic syndrome in pediatric patients","volume":"7","author":"Shin","year":"2019","journal-title":"Clin Nephrol Case Stud"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S2997","DOI":"10.14309\/01.ajg.0001048328.79663.64","article-title":"S4740 a case of small and large bowel ischemic ulcerations in a patient with atypical hemolytic uremic syndrome","volume":"119","author":"Camacho","year":"2024","journal-title":"Amer J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.14740\/jh205w","article-title":"An atypical case of atypical hemolytic uremic syndrome: predominant gastrointestinal involvement, intact renal function, and C5b-9 deposition in colon and skin","volume":"4","author":"De Yao","year":"2015","journal-title":"J Hematol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12882-020-01766-0","article-title":"Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome\u2014a case report","volume":"21","author":"Nunius","year":"2020","journal-title":"BMC Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3165\/jjpn.cr.2021.0195","article-title":"A case of aHUS with successful treated refractory hypertension for renin-angiotensin inhibitor, ischemic colitis for octreotide acetate","volume":"35","author":"Kuge","year":"2022","journal-title":"Jap J Pediatr Nephrology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.34067\/KID.0004952021","article-title":"Clear evidence of LAMA5 gene biallelic truncating variants causing infantile nephrotic syndrome","volume":"2","author":"Taniguchi","year":"2021","journal-title":"Kidney360"},{"key":"B15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201ckidney disease: improving global outcomes\u201d (KDIGO) controversies conference","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative protein structure modeling using modeller","volume":"54","author":"Webb","year":"2016","journal-title":"Curr Protoco Bioinformatics"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.02097","article-title":"Insights into enhanced complement activation by structures of properdin and its complex with the C-terminal domain of C3b","volume":"10","author":"van den Bos","year":"2019","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1021\/ci100241y","article-title":"Analyzing the topology of active sites: on the prediction of pockets and subpockets","volume":"50","author":"Volkamer","year":"2010","journal-title":"J. Chem. Inf. Model"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","article-title":"Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics","volume":"27","author":"Geerdink","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1007\/s10157-018-1549-3","article-title":"Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome","volume":"22","author":"Fujisawa","year":"2018","journal-title":"Clin Exp Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0124655","DOI":"10.1371\/journal.pone.0124655","article-title":"A novel quantitative hemolytic assay coupled with restriction fragment length polymorphisms analysis enabled early diagnosis of atypical hemolytic uremic syndrome and identified unique predisposing mutations in Japan","volume":"10","author":"Yoshida","year":"2015","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molimm.2012.12.006","article-title":"Analysis of genetic and predisposing factors in Japanese patients with atypical hemolytic uremic syndrome","volume":"54","author":"Fan","year":"2013","journal-title":"Mol Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.imlet.2004.10.010","article-title":"Engineering of human complement component C3 for catalytic inhibition of complement","volume":"98","author":"K\u00f6lln","year":"2005","journal-title":"Immunol Lett"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5540","DOI":"10.4049\/jimmunol.173.9.5540","article-title":"Complement inactivation by recombinant human C3 derivatives","volume":"173","author":"K\u00f6lln","year":"2004","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.4049\/jimmunol.2000752","article-title":"A complement C3-specific nanobody for modulation of the alternative cascade identifies the C-terminal domain of C3b as functional in C5 convertase activity","volume":"205","author":"Pedersen","year":"2020","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molimm.2006.06.017","article-title":"Structural insights into the central complement component C3","volume":"44","author":"Janssen","year":"2007","journal-title":"Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.bbadis.2010.09.002","article-title":"Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway","volume":"1812","author":"de C\u00f3rdoba","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.ekir.2021.03.885","article-title":"Risk of atypical HUS among family members of patients carrying complement regulatory gene abnormality","volume":"6","author":"Ardissino","year":"2021","journal-title":"Kidney Int Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","article-title":"Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"B32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MOP.0b013e32835df48a","article-title":"Complement disorders and hemolytic uremic syndrome","volume":"25","author":"Joseph","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12882-022-03022-z","article-title":"Serum and plasma levels of ba, but not those of soluble C5b-9, might be affected by renal function in chronic kidney disease patients","volume":"24","author":"Yamane","year":"2023","journal-title":"BMC Nephrol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol. Blood Marrow Transplant"},{"key":"B35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000492865","article-title":"Eculizumab modifies outcomes in adults with atypical hemolytic uremic syndrome with acute kidney injury","volume":"48","author":"Cao","year":"2018","journal-title":"Am J Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"446","DOI":"10.6515\/ACS.201809_34(5).20180326D","article-title":"Hypertensive crisis and refractory hypertension caused by atypical hemolytic uremic syndrome and effect of eculizumab","volume":"34","author":"Chen","year":"2018","journal-title":"Acta Cadiol Sin"},{"key":"B37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00467-014-2975-4","article-title":"Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension","volume":"30","author":"Ohta","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/0971-4065.181462","article-title":"Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome","volume":"27","author":"Raghunathan","year":"2017","journal-title":"Indian J Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1710286\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:44Z","timestamp":1769495984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1710286\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":39,"alternative-id":["10.3389\/fped.2025.1710286"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1710286","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1710286"}}